<SEC-DOCUMENT>0001564590-20-010887-index.html : 20200316 <SEC-HEADER>0001564590-20-010887.hdr.sgml : 20200316 <ACCEPTANCE-DATETIME>20200313180037 ACCESSION NUMBER: 0001564590-20-010887 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novus Therapeutics, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 20714393 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>nvus-pre14a_20200512.htm <DESCRIPTION>PRE 14A <TEXT> Document 1 - file: nvus-pre14a_20200512.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>gcs3q2abrj0e000005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: gcs3q2abrj0e000005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>gcs3q2abrj0e000002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: gcs3q2abrj0e000002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>gcs3q2abrj0e000004.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: gcs3q2abrj0e000004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>gcs3q2abrj0e000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: gcs3q2abrj0e000001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>gcs3q2abrj0e000003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: gcs3q2abrj0e000003.jpg
</DOCUMENT> </SEC-DOCUMENT>